{
  "id": "995677545a8b636f",
  "title": "STAT+: Ocular Therapeutix faces looming test of a more durable eye treatment",
  "description": "Ocular Therapeutix is nearing the completion of a head-to-head clinical trial that could be key for the company, investors, and patients.",
  "content": "Ocular Therapeutix is nearing the completion of a head-to-head clinical trial that could be key for the company, investors, and patients.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/08/ocular-therapeutix-wet-amd-axpaxli/?utm_campaign=rss",
  "published_at": "2026-01-08T11:30:00+00:00",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Ocular Therapeutix faces looming test of a more durable eye treatment",
    "description": "Ocular Therapeutix is nearing the completion of a head-to-head clinical trial that could be key for the company, investors, and patients.",
    "url": "https://www.statnews.com/2026/01/08/ocular-therapeutix-wet-amd-axpaxli/?utm_campaign=rss",
    "published": "2026-01-08T11:30:00+00:00",
    "source": "STAT"
  }
}